IN THE NEWS
Endpoints News
January 23, 2026Former FDA deputies land at Lilly, AbbVie; Italy’s Angelini has a new CEO
Progress Potential and Possibilities
January 23, 2026Dr. James Mackay, Ph.D. – CEO, Crystalys Therapeutics – Next Generation Treatments For Gout
The San Diego Union-Tribune
November 27, 2025Funding for San Diego startups tumbles to smallest quarterly investment total in 8 years
Pharmaceutical Technology
October 23, 2025Biotechs brush off sector headwinds in venture financing rebound
Clinical Trials Arena
October 22, 2025Crystalys Therapeutics begins Phase III trials for gout treatment
MedCity News
September 30, 2025Startup Crystalys Therapeutics Emerges With $205M to Fill a Growing Gap in Gout Treatment
FirstWord Pharma
September 30, 2025Crystalys makes its debut with $205M to advance next-gen gout drug
Fierce Biotech
September 30, 2025James Mackay is tending to ‘unfinished business’ with new gout biotech and $205M fundraise
Reuters
September 30, 2025Crystalys Therapeutics launches with $205 million funding round for trials of gout drug
Endpoints News
September 30, 2025